SJ
Therapeutic Areas
Cessation Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Anti-fentanyl monoclonal antibody (CSX-1004 inferred) | Prevention of fentanyl overdose | Phase 1 |
| Drug | Indication | Phase |
|---|---|---|
| Anti-fentanyl monoclonal antibody (CSX-1004 inferred) | Prevention of fentanyl overdose | Phase 1 |